ROIV
Income statement / Annual
Last year (2024), Roivant Sciences Ltd.'s total revenue was $124.80 M,
an increase of 103.65% from the previous year.
In 2024, Roivant Sciences Ltd.'s net income was $4.35 B.
See Roivant Sciences Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
| Operating Revenue |
$124.80 M
|
$61.28 M
|
$55.29 M
|
$23.80 M
|
$67.69 M
|
$2.32 M
|
| Cost of Revenue |
$15.56 M |
$13.13 M |
$8.97 M |
$2.06 M |
$1.13 M |
$606,000.00 |
| Gross Profit |
$109.24 M |
$48.15 M |
$46.32 M |
$21.74 M |
$66.56 M |
$1.72 M |
| Gross Profit Ratio |
0.88 |
0.79 |
0.84 |
0.91 |
0.98 |
0.74 |
| Research and Development
Expenses |
$501.74 M
|
$525.22 M
|
$483.04 M
|
$236.63 M
|
$263.22 M
|
$512.99 M
|
| General & Administrative
Expenses |
$0.00
|
$600.51 M
|
$775.03 M
|
$259.88 M
|
$335.77 M
|
$237.21 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$687.44 M
|
$600.51 M
|
$775.03 M
|
$259.88 M
|
$335.77 M
|
$237.21 M
|
| Other Expenses |
-$85.03 M |
-$62.19 M |
-$81,000.00 |
-$33.41 M |
$0.00 |
$0.00 |
| Operating Expenses |
$1.19 B |
$1.13 B |
$1.26 B |
$496.50 M |
$598.98 M |
$750.21 M |
| Cost And Expenses |
$1.20 B |
$1.14 B |
$1.27 B |
$498.56 M |
$600.11 M |
$750.81 M |
| Interest Income |
$146.43 M |
$32.18 M |
$369,000.00 |
$1.42 M |
$17.99 M |
$5.83 M |
| Interest Expense |
$34.78 M |
$27.97 M |
$7.04 M |
$2.81 M |
$7.68 M |
$7.54 M |
| Depreciation &
Amortization |
$22.04 M
|
$26.42 M
|
$5.93 M
|
$474.77 M
|
$532.42 M
|
$748.49 M
|
| EBITDA |
-$996.52 M
|
-$1.11 B
|
-$1.50 B
|
-$510.50 M
|
$83.85 M
|
$138.13 M
|
| EBITDA Ratio |
-7.99 |
-18.07 |
-27.13 |
-21.45 |
1.24 |
59.43 |
| Operating Income Ratio
|
33.99
|
-17.58
|
-21.92
|
-45.01
|
-7.87
|
-322.07
|
| Total Other
Income/Expenses Net |
$5.22 B
|
-$147.27 M
|
$288.00 M
|
$172.35 M
|
-$28.56 M
|
-$58.69 M
|
| Income Before Tax |
$4.25 B |
-$1.22 B |
-$923.75 M |
-$898.55 M |
-$560.99 M |
-$807.18 M |
| Income Before Tax Ratio
|
34.08
|
-19.99
|
-16.71
|
-37.76
|
-8.29
|
-347.32
|
| Income Tax Expense |
$22.22 M |
$5.19 M |
$369,000.00 |
$1.69 M |
$7.12 M |
$2.62 M |
| Net Income |
$4.35 B |
-$1.23 B |
-$924.12 M |
-$900.23 M |
$1.20 B |
-$1.04 B |
| Net Income Ratio |
34.85 |
-20.07 |
-16.72 |
-37.83 |
17.74 |
-448.35 |
| EPS |
5.55 |
-1.73 |
-1.38 |
-4.04 |
5.21 |
-4.84 |
| EPS Diluted |
5.23 |
-1.73 |
-1.38 |
-4.04 |
5.21 |
-4.84 |
| Weighted Average Shares
Out |
$783.25 M
|
$712.79 M
|
$669.75 M
|
$222.67 M
|
$215.35 M
|
$215.35 M
|
| Weighted Average Shares
Out Diluted |
$831.05 M
|
$712.79 M
|
$669.75 M
|
$222.67 M
|
$215.35 M
|
$215.35 M
|
| Link |
|
|
|
|
|
|
